1331776-45-4

Basic information

• Product Name: 6-butyl-5-(4-cyclohexyloxy-phenyl)-4-trifluoromethyl-2H-pyridazin-3-one
• Synonyms: 6-butyl-5-(4-cyclohexyloxy-phenyl)-4-trifluoromethyl-2H-pyridazin-3-one
• CAS NO: 1331776-45-4
• Molecular Weight: 394.437
• Mol File: 1331776-45-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 6-butyl-5-(4-cyclohexyloxy-phenyl)-4-trifluoromethyl-2H-pyridazin-3-one(CAS DataBase Reference)
• NIST Chemistry Reference: 6-butyl-5-(4-cyclohexyloxy-phenyl)-4-trifluoromethyl-2H-pyridazin-3-one(1331776-45-4)
• EPA Substance Registry System: 6-butyl-5-(4-cyclohexyloxy-phenyl)-4-trifluoromethyl-2H-pyridazin-3-one(1331776-45-4)

Safety Data

• Hazardous Substances Data: 1331776-45-4(Hazardous Substances Data)

Upstream product

• 1331776-44-3 3-(4-cyclohexyloxyphenyl)-4-oxo-2-trifluoromethyl-oct-2-enoic acid methyl ester 
• 1046140-44-6 (4-cyclohexyloxyphenyl)acetic acid methyl ester 
• 1331775-49-5 1-(4-cyclohexyloxyphenyl)hexan-2-one 
• 138113-75-4 (4-cyclohexyloxyphenyl)acetic acid 
• 14199-15-6 Methyl 4-hydroxyphenylacetate 

Downstream Products

• 1331776-47-6 4-[6-butyl-5-(4-cyclohexyloxyphenyl)-4-trifluoromethylpyridazin-3-yloxy]piperidine-1-carboxylic acid tert-butyl ester 
• 1331776-46-5 3-butyl-6-chloro-4-(4-cyclohexyloxyphenyl)-5-trifluoromethylpyridazine 

Relevant articles and documents

PHENYL-HETEROARYL DERIVATIVES AND METHODS OF USE THEREOF

The present invention provides phenyl-heteroaryl derivatives of Formula (I) and pharmaceutically acceptable salts thereof. These compounds are useful in the treatment of RAGE-mediated diseases such as Alzheimer's Disease. The present invention further relates to methods for the preparation of compounds of Formula (I) and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising such compounds, and the use of such compounds and/or pharmaceutical compositions in treating RAGE-mediated diseases.